CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CNCR was delisted on the 27th of May, 2025.

Back to rankings

11 hedge funds and large institutions have $901K invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$77.8K

Top Sellers

1
-$308K
2
-$228K
3
-$143K
4
Focus Partners Wealth
Focus Partners Wealth
Massachusetts
-$51.1K
5
RIA
Realta Investment Advisors
Delaware
-$7.28K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$558K
2
$165K
3
$79.9K
4
$75.4K
5
$10.8K
6
$4.49K
7
$3.15K
8
$2.24K
9
$1.5K
10
$1K
11
$403
12
$7
13
–
14
–